Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Cancer Genet Cytogenet. 2010 May;199(1):15–20. doi: 10.1016/j.cancergencyto.2010.01.014

Table 1.

Patient ID Age/Gender CR Relapse DFS (Months) Deletion
99-350 43/F Yes No 115+ CDKN2A, 9q34
99-1069 52/M Yes Yes 6 CDKN2A
00-307 68/M No CDKN2A
00-947* 70/M Yes Yes 25 9q34
01-782 56/M Yes No 85+
02-231 53/M No
02-1252* 21/F Yes Yes 21
06-063 68/M No
05-1528 42/F No 9q34
07-874 68/M Yes No 15+

Abbreviations: CR, complete remission, DFS, disease-free survival; F, female; M, male

*

Two samples with <60% blasts were sorted according to the diagnostic immunophenotypic pattern.